¼¼°èÀÇ ÇコÄɾî¿ë Ư±Ç ¾×¼¼½º °ü¸® ½ÃÀå
Privileged Access Management in Healthcare
»óǰÄÚµå : 1773869
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 381 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇコÄɾî¿ë Ư±Ç ¾×¼¼½º °ü¸® ¼¼°è ½ÃÀåÀº 2030³â±îÁö 4¾ï 2,870¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 2¾ï 5,240¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇコÄɾî¿ë Ư±Ç ¾×¼¼½º °ü¸® ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 9.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 4¾ï 2,870¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠƯ±Ç ¾îÄ«¿îÆ® ¹× ¼¼¼Ç °ü¸® ¼­ºñ½º´Â CAGR 8.4%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 8,540¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ư±Ç ½Â°Ý ¹× ±ÇÇÑ À§¾ç °ü¸® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 8.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 6,880¸¸ ´Þ·¯, Áß±¹Àº CAGR 12.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÇコÄɾî¿ë Ư±Ç ¾×¼¼½º °ü¸® ½ÃÀåÀº 2024³â¿¡ 6,880¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 8,600¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 12.5%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 6.7%¿Í 8.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 7.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ÇコÄɾî¿ë Ư±Ç ¾×¼¼½º °ü¸® ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃßÁø ¿äÀÎ ¿ä¾à

Ư±Ç ¾×¼¼½º °ü¸®°¡ ÇコÄÉ¾î »çÀ̹ö º¸¾È¿¡¼­ Áß¿äÇÑ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Ư±Ç ¾×¼¼½º °ü¸®(PAM)´Â Á¶Á÷ÀÌ µ¥ÀÌÅÍ À¯Ãâ, ·£¼¶¿þ¾î °ø°Ý, ÀÎ½Ãµå ¸®½ºÅ© µîÀÇ À§Çù¿¡ Á÷¸éÇÔ¿¡ µû¶ó ÇコÄÉ¾î »ê¾÷¿¡¼­ ÇʼöÀûÀÎ »çÀ̹ö º¸¾È ¼Ö·ç¼ÇÀÌ µÇ°í ÀÖ½À´Ï´Ù. PAM ¼Ö·ç¼ÇÀº ¾ö°ÝÇÑ ÀÎÁõ ÇÁ·ÎÅäÄÝÀ» Àû¿ëÇϰí, ±ÇÇÑ ÀÖ´Â »ç¿ëÀÚÀÇ È°µ¿À» ¸ð´ÏÅ͸µÇϰí, ±ÇÇÑÀÌ ÀÖ´Â »ç¿ëÀÚÀÇ È°µ¿À» °¨½ÃÇϰí, ¹«´Ü ¾×¼¼½ºÀÇ À§ÇèÀ» ÁÙÀÓÀ¸·Î½á Áß¿äÇÑ ½Ã½ºÅÛ¿¡ ´ëÇÑ Á¢±ÙÀ» Â÷´ÜÇÕ´Ï´Ù. Áß¿ä ½Ã½ºÅÛ¿¡ ´ëÇÑ Á¢±ÙÀÇ ¾ÈÀüÀ» º¸ÀåÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ ÀúÀå¼Ò, IoT Áö¿ø ÀÇ·á±â±â, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ µî ÇコÄɾîÀÇ µðÁöÅÐÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó °­·ÂÇÑ ¾×¼¼½º Á¦¾îÀÇ Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, HIPAA, GDPR, HITRUST µîÀÇ ±ÔÁ¤ Áؼö ¿ä±¸»çÇ×Àº ¾ö°ÝÇÑ ID ¹× ¾×¼¼½º °ü¸® °üÇàÀ» ¿ä±¸Çϰí ÀÖÀ¸¸ç, ÇコÄɾî Á¶Á÷Àº ÀÎÇÁ¶ó¸¦ º¸È£Çϱâ À§ÇØ PAM ¼Ö·ç¼ÇÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î »çÀ̹ö º¸¾È À§ÇùÀÌ °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥, PAMÀº µ¥ÀÌÅÍ º¸È£ °­È­, º¸¾È Ãë¾à¼º °¨¼Ò, ±ÔÁ¦ Áؼö º¸Àå¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ßÀÇ Æ¯±Ç ¾×¼¼½º °ü¸® µµÀÔÀ» ¹æÇØÇÏ´Â ¿ä¼Ò´Â ¹«¾ùÀΰ¡?

±× Á߿伺¿¡µµ ºÒ±¸Çϰí, ÇコÄÉ¾î ºÐ¾ß¿¡¼­ PAM ¼Ö·ç¼ÇÀÇ ±¤¹üÀ§ÇÑ µµÀÔÀº µµÀÔ°ú È¿À²¼º¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸î °¡Áö ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿ì·Á »çÇ× Áß Çϳª´Â PAMÀ» ±âÁ¸ ÇコÄɾî IT »ýŰ迡 ÅëÇÕÇÏ´Â °ÍÀÌ º¹ÀâÇÏ´Ù´Â °ÍÀÔ´Ï´Ù. ÀÌ »ýŰ迡´Â Á¾Á¾ ¿À·¡µÈ ·¹°Å½Ã ½Ã½ºÅÛÀ̳ª ´ÜÆíÈ­µÈ ³×Æ®¿öÅ©°¡ Æ÷ÇԵǾî ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¸¹Àº ÇコÄɾî Á¶Á÷Àº PAM ¼Ö·ç¼ÇÀÇ ¼³Á¤ ¹× À¯Áöº¸¼ö¿¡ ÇÊ¿äÇÑ ±â¼úÀû Àü¹®¼ºÀ» °®ÃßÁö ¸øÇØ µµÀÔÀÌ Áö¿¬µÇ°í ÀáÀçÀûÀÎ º¸¾È °ø¹éÀÌ ¹ß»ýÇÕ´Ï´Ù. ¶ÇÇÑ, PAM ¼Ö·ç¼ÇÀº ¼ÒÇÁÆ®¿þ¾î, ±³À°, ÀÎÇÁ¶ó ¾÷±×·¹À̵忡 ¸¹Àº ÅõÀÚ°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ ºñ¿ëÀûÀÎ Á¦¾àÀÌ Å« ¹®Á¦À̸ç, ¼Ò±Ô¸ð º´¿øÀ̳ª Ŭ¸®´Ð¿¡¼­´Â PAMÀ» °ü¸® ºÎ´ãÀÇ Áõ°¡·Î ÀνÄÇÏ´Â ÀÇ·áÁøµéÀÇ º¯È­¿¡ ´ëÇÑ ÀúÇ×À¸·Î ÀÎÇØ µµÀÔ¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. º¯È­¿¡ ´ëÇÑ ÀúÇ×ÀÌ µµÀÔÀ» ´õ¿í ´ÊÃß°í ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ °úÁ¦´Â ƯÈ÷ ¿ø°ÝÀÇ·á ¹× ¸ð¹ÙÀÏ ÇコÄÉ¾î ¾ÖÇø®ÄÉÀ̼ÇÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿©·¯ ±â±â¿Í Àå¼Ò¿¡ °ÉÄ£ ¿øÈ°ÇÑ ¾×¼¼½º °ü¸®¸¦ º¸ÀåÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ PAM ¼Ö·ç¼Ç, ·¹°Å½Ã ½Ã½ºÅÛ°úÀÇ »óÈ£¿î¿ë¼º °­È­, ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ »çÀ̹ö º¸¾È ±³À°¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù.

AI¿Í Á¦·Î Æ®·¯½ºÆ® ¸ðµ¨Àº ÇコÄɾ¼­ Ư±Ç ¾×¼¼½º °ü¸®¸¦ ¾î¶»°Ô °­È­ÇÒ ¼ö ÀÖÀ»±î?

ÀΰøÁö´É°ú Á¦·Î Æ®·¯½ºÆ® º¸¾È ¸ðµ¨ÀÇ ±â¼úÀû ¹ßÀüÀº ÇコÄÉ¾î ºÐ¾ßÀÇ PAM ¼Ö·ç¼Ç¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖÀ¸¸ç, AI ±â¹Ý PAM ÅøÀº »ç¿ëÀÚ ÇൿÀ» Áö¼ÓÀûÀ¸·Î ºÐ¼®ÇÏ¿© ÀÌ»ó ¡Èĸ¦ °¨ÁöÇϰí, Àǽɽº·¯¿î Á¢±Ù ½Ãµµ¸¦ ½Ç½Ã°£À¸·Î °æ°íÇÏ¿© º¸¾ÈÀ» °­È­ÇÕ´Ï´Ù. Àǽɽº·¯¿î Á¢±Ù ½Ãµµ¿¡ ´ëÇØ ½Ç½Ã°£À¸·Î °æ°í¸¦ ¹ß·ÉÇÏ¿© º¸¾ÈÀ» °­È­ÇÕ´Ï´Ù. ÀÚµ¿È­µÈ À§Çè ±â¹Ý ÀÎÁõÀº »ç¿ëÀÚÀÇ À§Ä¡, ±â±â, Çൿ ÆÐÅÏ¿¡ µû¶ó º¸¾È Á¶Ä¡¸¦ µ¿ÀûÀ¸·Î Á¶Á¤ÇÏ¿© Á¢±Ù Á¦¾î¸¦ °³¼±ÇÕ´Ï´Ù. Á¦·Î Æ®·¯½ºÆ® º¸¾È ÇÁ·¹ÀÓ¿öÅ©ÀÇ Ã¤ÅÃÀº Áß¿äÇÑ ÇコÄÉ¾î ½Ã½ºÅÛ¿¡ Á¢±ÙÇÏ´Â ¸ðµç »ç¿ëÀÚ¿Í ±â±â¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÀÎÁõÀ» ¿ä±¸ÇÏ´Â 'Àý´ë ½Å·ÚÇÏÁö ¸»°í Ç×»ó °ËÁõÇ϶ó'´Â Á¢±Ù ¹æ½ÄÀ» °­Á¦ÇÔÀ¸·Î½á Ư±Ç ¾×¼¼½º °ü¸®¸¦ ´õ¿í °­È­ÇÕ´Ï´Ù. ¶ÇÇÑ, ºí·ÏüÀÎ ±â¼úÀº Ư±Ç ÀÚ°Ý Áõ¸íÀ» °ü¸®ÇÏ´Â ¾ÈÀüÇÑ ¹æ¹ýÀ¸·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, ID »ç±â ¹× ¹«´Ü ¾×¼¼½ºÀÇ À§ÇèÀ» °¨¼Ò½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ó±¼ ÀνÄÀ̳ª Áö¹® ½ºÄµ°ú °°Àº »ýüÀÎ½Ä ÀÎÁõÀÇ ÅëÇÕÀº ±ÇÇÑ ÀÖ´Â »ç¿ëÀÚ¿¡ ´ëÇÑ º¸¾ÈÀ» °­È­ÇÏ¿© ±ÇÇÑÀÌ ºÎ¿©µÈ »ç¶÷¸¸ Áß¿äÇÑ ÀÇ·á µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó PAM ¼Ö·ç¼ÇÀº ´õ¿í Áö´ÉÈ­, ÀÚµ¿È­ ¹× »çÀ̹ö À§Çù¿¡ °­ÇØÁö°í ÀÖ½À´Ï´Ù.

ÇコÄɾî¿ë Ư±Ç ¾×¼¼½º °ü¸® ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

ÇコÄɾî¿ë Ư±Ç ¾×¼¼½º °ü¸® ½ÃÀåÀÇ ¼ºÀåÀº »çÀ̹ö º¸¾È À§ÇùÀÇ Áõ°¡, ±ÔÁ¦ Áؼö ¿ä±¸ »çÇ×ÀÇ °­È­, µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ±Þ¼ÓÇÑ È®Àå µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. º´¿ø°ú ÀÇ·á ±â°üÀ» ´ë»óÀ¸·Î ÇÑ ·£¼¶¿þ¾î °ø°ÝÀÇ ºóµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áß¿äÇÑ ½Ã½ºÅÛ ¹× ȯÀÚ µ¥ÀÌÅ͸¦ º¸È£Çϱâ À§ÇÑ PAM ¼Ö·ç¼Ç µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ Á¢±Ù °ü¸® Á¶Ä¡¸¦ Àǹ«È­ÇÏ´Â Á¤ºÎ ±ÔÁ¦´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖÀ¸¸ç, ÀÇ·á ±â°üÀº °­·ÂÇÑ ID °ü¸® ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÒ ¼ö¹Û¿¡ ¾ø´Â »óȲÀÔ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ÇコÄɾî Ç÷§Æû, IoT ÀÇ·á±â±â, ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È®»êÀº ¾ÈÀüÇÏ°í ¿øÈ°ÇÑ Á¢±Ù °ü¸®¸¦ Á¦°øÇÏ´Â °í±Þ PAM ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI ±â¹Ý º¸¾È ÀÚµ¿È­ ¹× Çൿ ºÐ¼®À¸·ÎÀÇ ÀüȯÀº PAM ½Ã½ºÅÛÀÇ È¿À²¼ºÀ» ³ôÀ̰í ÇコÄÉ¾î ±â¾÷ Àü¹Ý¿¡ °ÉÃÄ PAM ½Ã½ºÅÛ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾîÀÇ µðÁöÅÐ ÀüȯÀÌ °è¼ÓµÇ´Â °¡¿îµ¥, º¸´Ù ¾ÈÀüÇϰí ÄÄÇöóÀ̾𽺸¦ ÁؼöÇÏ´Â ÇコÄɾî ȯ°æÀ» º¸ÀåÇϱâ À§ÇØ °í±Þ Ư±Ç ¾×¼¼½º °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù.

ºÎ¹®

¼Ö·ç¼Ç À¯Çü(Ư±Ç ¾îÄ«¿îÆ® ¹× ¼¼¼Ç °ü¸® ¼­ºñ½º, Ư±Ç ½Â°Ý ¹× ±ÇÇÑ À§¾ç °ü¸®, ºñ¹Ð °ü¸®, ±âŸ ¼Ö·ç¼Ç À¯Çü), Àü°³ ¹æ½Ä(Ŭ¶ó¿ìµå Àü°³, ¿ÂÇÁ·¹¹Ì½º Àü°³, ÇÏÀ̺긮µå Àü°³), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ¹× Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, »ý¸í°úÇÐ ±â¾÷ ÃÖÁ¾»ç¿ëÀÚ, ÀÇ·áºñ ÁöºÒÀÚ ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è µµ¸ÞÀÎ Àü¹®°¡°¡ ¼±º°ÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Privileged Access Management in Healthcare Market to Reach US$428.7 Million by 2030

The global market for Privileged Access Management in Healthcare estimated at US$252.4 Million in the year 2024, is expected to reach US$428.7 Million by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Privileged Account & Session Management Services, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$185.4 Million by the end of the analysis period. Growth in the Privilege Elevation & Delegation Management segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$68.8 Million While China is Forecast to Grow at 12.5% CAGR

The Privileged Access Management in Healthcare market in the U.S. is estimated at US$68.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$86.0 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Privileged Access Management in Healthcare Market - Key Trends & Drivers Summarized

Why Is Privileged Access Management Critical in Healthcare Cybersecurity?

Privileged Access Management (PAM) has become a vital cybersecurity solution in the healthcare industry as organizations face rising threats of data breaches, ransomware attacks, and insider risks. Healthcare institutions manage vast amounts of sensitive patient data, including electronic health records (EHRs), financial information, and proprietary medical research, making them prime targets for cybercriminals. PAM solutions help secure access to critical systems by enforcing strict authentication protocols, monitoring privileged user activities, and mitigating unauthorized access risks. The increasing digitization of healthcare, including cloud-based data storage, IoT-enabled medical devices, and remote patient monitoring, has further emphasized the need for robust access controls. Additionally, compliance requirements under regulations such as HIPAA, GDPR, and HITRUST mandate strict identity and access management practices, prompting healthcare organizations to adopt PAM solutions to safeguard their infrastructure. As healthcare cybersecurity threats continue to evolve, PAM is playing an essential role in enhancing data protection, reducing security vulnerabilities, and ensuring regulatory compliance.

What Challenges Are Hindering the Adoption of Privileged Access Management in Healthcare?

Despite its importance, the widespread implementation of PAM solutions in healthcare faces several challenges that impact adoption and efficiency. One of the key concerns is the complexity of integrating PAM into existing healthcare IT ecosystems, which often include outdated legacy systems and fragmented networks. Many healthcare organizations lack the necessary technical expertise to configure and maintain PAM solutions, leading to implementation delays and potential security gaps. Additionally, cost constraints pose a significant challenge, as PAM solutions require substantial investment in software, training, and infrastructure upgrades, making adoption difficult for smaller hospitals and clinics. Resistance to change among healthcare staff, who may perceive PAM as an additional layer of administrative burden, further slows down deployment. Another challenge is ensuring seamless access management across multiple devices and locations, particularly with the growing use of telehealth and mobile healthcare applications. Addressing these challenges requires user-friendly PAM solutions, enhanced interoperability with legacy systems, and strategic investments in cybersecurity training for healthcare professionals.

How Are AI and Zero Trust Models Enhancing Privileged Access Management in Healthcare?

Technological advancements in artificial intelligence and zero trust security models are revolutionizing PAM solutions in healthcare, making them more proactive, adaptive, and efficient. AI-driven PAM tools are enhancing security by continuously analyzing user behavior, detecting anomalies, and triggering real-time alerts for suspicious access attempts. Automated risk-based authentication is improving access control by dynamically adjusting security measures based on user location, device, and activity patterns. The adoption of zero trust security frameworks is further strengthening privileged access management by enforcing a "never trust, always verify" approach, requiring continuous authentication for all users and devices accessing critical healthcare systems. Additionally, blockchain technology is emerging as a secure method for managing privileged credentials, reducing the risk of identity fraud and unauthorized access. The integration of biometric authentication, such as facial recognition and fingerprint scanning, is also enhancing security measures for privileged users, ensuring that only authorized personnel can access sensitive healthcare data. As these technologies continue to evolve, PAM solutions are becoming more intelligent, automated, and resilient against cyber threats.

What Is Driving the Growth of the Privileged Access Management in Healthcare Market?

The growth in the privileged access management in healthcare market is driven by several factors, including increasing cybersecurity threats, stricter regulatory compliance requirements, and the rapid expansion of digital health solutions. The rising frequency of ransomware attacks targeting hospitals and healthcare institutions has accelerated the adoption of PAM solutions to protect critical systems and patient data. Government regulations mandating strict access control measures have further fueled market growth, compelling healthcare organizations to invest in robust identity management solutions. The proliferation of cloud-based healthcare platforms, IoT medical devices, and telehealth services has also increased the demand for advanced PAM solutions that provide secure and seamless access management. Additionally, the shift toward AI-driven security automation and behavioral analytics is enhancing the effectiveness of PAM systems, driving adoption across healthcare enterprises. As healthcare continues to undergo digital transformation, the need for sophisticated privileged access management solutions will continue to grow, ensuring a more secure and compliant healthcare environment.

SCOPE OF STUDY:

The report analyzes the Privileged Access Management in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Solution Type (Privileged Account & Session Management Services, Privilege Elevation & Delegation Management, Secrets Management, Other Solution Types); Deployment Type (Cloud Deployment, On-Premise Deployment, Hybrid Deployment); End-Use (Hospitals & Clinics End-Use, Life Science Companies End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â